Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in BTAIQ — BioXcel Therapeutics, Inc.

CIK 19617 NEW YORK, NY
Back to BTAIQ Full portfolio

Position in BTAIQ

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$63
+$3 QoQ
Shares Held
45
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 47 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BTAIQ Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $2,415,050,910 across 61 Drug Manufacturers - Specialty & Generic names. BTAIQ ranks #60 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
 6,398,674 $1,078,432,506
2 TEVA
Teva Pharmaceutical Industries Ltd
 6,981,234 $236,524,202
3 ZTS
Zoetis Inc.
 2,624,825 $188,619,917
4 HIMS
Hims & Hers Health, Inc.
 4,766,781 $165,264,292
5 UTHR
UNITED THERAPEUTICS Corp
 275,358 $149,197,220
6 VTRS
Viatris Inc
 7,322,267 $116,277,595
7 HLN
Haleon plc
 10,824,395 $100,991,599
8 LNTH
Lantheus Holdings, Inc.
 699,229 $77,572,458

All Filings in BTAIQ

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $63 45
2025-12-31 $72 45
2025-09-30 $115 45
2025-06-30 $81 45
2025-03-31 $235 116
2024-12-31 — 1,328
2024-09-30 — 749
2024-06-30 — 749
2024-03-31 — 8,936
2023-12-31 — 12,703
2023-09-30 — 12,808
2023-06-30 — 21,440
2023-03-31 — 17,291
2022-12-31 — 11,595
2022-09-30 — 10,589
2022-06-30 — 10,378
2022-03-31 — 13,606
2021-12-31 — 11,736
2021-09-30 — 10,953
2021-06-30 — 9,481
2021-03-31 — 8,212
2020-12-31 — 5,807
2020-09-30 — 4,375
2020-06-30 — 3,565
2020-03-31 — 2,222